KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non Operating Income: 2017-2025

Historic Non Operating Income for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Sep 2025 value amounting to -$237.0 million.

  • Teva Pharmaceutical Industries' Non Operating Income rose 12.87% to -$237.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$932.0 million, marking a year-over-year increase of 7.91%. This contributed to the annual value of -$981.0 million for FY2024, which is 7.19% up from last year.
  • Teva Pharmaceutical Industries' Non Operating Income amounted to -$237.0 million in Q3 2025, which was up 5.95% from -$252.0 million recorded in Q2 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Non Operating Income registered a high of -$211.0 million during Q2 2022, and its lowest value of -$290.0 million during Q1 2021.
  • For the 3-year period, Teva Pharmaceutical Industries' Non Operating Income averaged around -$250.2 million, with its median value being -$250.0 million (2024).
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Non Operating Income plummeted by 105.98% in 2021, and later rose by 22.99% in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Non Operating Income (Quarterly) stood at -$253.0 million in 2021, then climbed by 3.16% to -$245.0 million in 2022, then declined by 1.63% to -$249.0 million in 2023, then grew by 12.45% to -$218.0 million in 2024, then rose by 12.87% to -$237.0 million in 2025.
  • Its Non Operating Income was -$237.0 million in Q3 2025, compared to -$252.0 million in Q2 2025 and -$225.0 million in Q1 2025.